PATENT CLAIM ANALYSIS

Application Number: 16229431
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["530", "350000"]

Abstract:
Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.

Claim (Index 1):
A hybrid nuclease molecule comprising a first nuclease domain and a modified Fc domain, wherein the first nuclease domain is operatively coupled to the Fc domain and wherein the Fc domain is modified such that the molecule has reduced cytotoxicity relative to a hybrid nuclease molecule having an unmodified Fc domain.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.52632
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13822215', '14599567', '14174167', '14516161', '13197731']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7598699669874902
- 35 USC 102 Novelty (BERT): 0.5700319882846466
- Combined Prediction Score: 0.740886169117206
- Mean Citation Score: 489.8245999999999
- Max Citation Score: 564.5039
- Similarity Product: 377.83448341233736

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test